Parallel importation of pharmaceuticals in the US and Europe
Pharmaceuticals Discussion Intellectual Property Partner, Nick Phillips discusses parallel importation of pharmaceuticals in the US and Europe in this IPPro Life Sciences article. IPPro Life Sciences…
Read the full articleYou might also wanna read
Europe–US new drug manufacturing outsourcing gap widens, reveals GlobalData
Contract manufacturing facilities located in the US and Europe provide biopharma companies with strategic options to diversify supply chains
CPA Welcomes FDA Proposal to Expose Hidden Foreign Suppliers in America’s Drug Supply Chain
For years, the most critical link in our drug supply chain — the upstream chemistry — has been invisible to our own regulators. A medicine f
Harmonising access and reinventing the procurement of innovative medicines in Europe
Europe pays for innovative medicines through 27 uncoordinated national negotiations, generating access delays, cross-country pricing externa
UK-India trade agreement does not support UK life sciences ambitions, says ABPI
The ABPI is disappointed that the deal does not appear to address longstanding industry concerns about intellectual property protections for
European biotech leaders explore China's role in global life sciences innovation at Paris roundtable
A recent roundtable discussion at our Paris office explored the evolving role of China in the global biotechnology ecosystem and the opportu
jdsupra.com·23d ago
Explained: How the India-UK CETA could boost pharma, medtech exports
The UK imports nearly $30 billion worth of pharmaceutical products every year. Despite India’s reputation as the “pharmacy of the world” and
Comments
Sign in to join the conversation.
No comments yet. Be the first.